PLAAT4 and breast carcinoma: Knockdown, and overexpression, of RARRES3 in near-normal mammary epithelial cells and breast cancer cell lines confirm a capacity of the retinoid-responder gene to modulate the IP catalytic subunits both at transcriptional and protein levels, suggesting a novel regulatory role of RARRES3 in breast cancer.